Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024
Same author

Human intestinal microbiome: Role in health and disease.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024
Same author

Meningococcal meningitis in Spain in the Horizon 2030: A position paper.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024
Same author

Respiratory syncytial virus: A new era.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024
Same author

COVID-19: On the threshold of the fifth year. The situation in Spain.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2023
Same author

Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2023

Related Experiment Video

Updated: Jul 1, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K

Tuberculosis in Spain: An opinion paper.

S Moreno Guillén, F J Rodríguez-Artalejo, J Ruiz-Galiana

  • 1Servicio de Microbiología Clínica y Enfermedades Infecciosas del Hospital General Universitario Gregorio Marañón, Universidad Complutense. CIBERES. Ciber de Enfermedades Respiratorias. Madrid, Spain. emilio.bouza@gmail.com.

Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|November 3, 2023
PubMed
Summary

This review examines the current state of tuberculosis (TB) in Spain, covering incidence, at-risk groups, and treatment advances. It highlights new diagnostics, drug therapies, and vaccines to combat this persistent infectious disease.

Keywords:
Intensive Care UnitTuberculosisbedaquilinedelamanidextrapulmonary tuberculosisincidencelatent tuberculosismedical-legal aspectsmicrobiological diagnosisnew drugspediatric tuberculosispopulations at riskrecurrencesituation in Spaintreatmentvaccines

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.8K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.0K

Related Experiment Videos

Last Updated: Jul 1, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.8K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.0K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Tuberculosis (TB) remains a significant global health challenge, with evolving incidence and risk populations.
  • Spain faces specific challenges in TB control, necessitating a review of current strategies.
  • The Committee on Emerging Pathogens and COVID-19 of ICOMEM convened to address the contemporary landscape of tuberculosis.

Purpose of the Study:

  • To provide a comprehensive overview of the current situation of tuberculosis in Spain.
  • To analyze epidemiological trends, vulnerable populations, and healthcare delivery for TB patients.
  • To discuss advancements in diagnostics, therapeutics, and preventative measures, including vaccines.

Main Methods:

  • Review of epidemiological data on tuberculosis incidence and prevalence in Spain.
  • Analysis of healthcare circuits and patient management strategies for tuberculosis.
  • Evaluation of diagnostic tools, including molecular biology techniques.
  • Assessment of current and novel anti-tuberculosis drugs, including resistance patterns.
  • Discussion of treatment strategies, direct observation therapy, and treatment duration.
  • Review of special populations (pediatric, surgical, intensive care) and vaccine status (BCG, future vaccines).

Main Results:

  • Molecular biology has transformed the perspective and diagnosis of tuberculosis.
  • Newer drugs and shortened treatment regimens are improving outcomes.
  • Directly observed therapy remains crucial for treatment adherence.
  • BCG vaccine status and future vaccine development are critical for eradication efforts.
  • Ethical and medicolegal aspects of tuberculosis management require careful consideration.

Conclusions:

  • Tuberculosis management has advanced significantly with new diagnostics and therapeutics.
  • Shortened treatment durations and adherence strategies are key to reducing relapse.
  • Vaccine development and ethical considerations are vital for the long-term goal of TB eradication.
  • A multidisciplinary approach is essential for controlling tuberculosis in Spain and globally.